ACNP task force report on SSRIs and suicidal behavior in youth

J. John Mann, Graham Emslie, Ross J. Baldessarini, William Beardslee, Jan A. Fawcett, Frederick K. Goodwin, Andrew C. Leon, Herbert Y. Meltzer, Neal D. Ryan, David Shaffer, Karen D. Wagner

Research output: Contribution to journalReview article

114 Scopus citations

Abstract

This Task Force report by the American College of Neuropsychopharmacology evaluates the safety and efficacy of selective serotonin reuptake inhibitor (SSRIs) antidepressants for depressed youth under 18 years. The report was undertaken after regulatory agencies in the United States and United Kingdom raised concerns in 2003 about the possibility that treatment of depression in children and adolescents with SSRIs may increase the risk of suicidal thinking or suicide attempts.

Original languageEnglish (US)
Pages (from-to)473-492
Number of pages20
JournalNeuropsychopharmacology
Volume31
Issue number3
DOIs
StatePublished - Mar 1 2006

Keywords

  • Adolescents
  • Adults
  • Antidepressants
  • Children
  • Suicide
  • Suicide attempts

ASJC Scopus subject areas

  • Pharmacology
  • Psychiatry and Mental health

Fingerprint Dive into the research topics of 'ACNP task force report on SSRIs and suicidal behavior in youth'. Together they form a unique fingerprint.

  • Cite this

    Mann, J. J., Emslie, G., Baldessarini, R. J., Beardslee, W., Fawcett, J. A., Goodwin, F. K., Leon, A. C., Meltzer, H. Y., Ryan, N. D., Shaffer, D., & Wagner, K. D. (2006). ACNP task force report on SSRIs and suicidal behavior in youth. Neuropsychopharmacology, 31(3), 473-492. https://doi.org/10.1038/sj.npp.1300958